Markets:

Overview

News

Currencies

International

Treasuries

Gilead Sciences (NQ:GILD)

151.40 +0.28 (+0.19%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Gilead Sciences

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

71 72 Next >

Biotech Bull Market Is Intact But SMIDs Are Too Volatile ↗

July 22, 2024

It was another wild week for the market as it had to contend with a lot of news.

Via Talk Markets

Breaking Down Gilead Sciences: 10 Analysts Share Their Views ↗

July 22, 2024

Via Benzinga

Gilead and the Elton John AIDS Foundation Announce Additional Five Years of RADIAN Partnership to Help Address the Growing HIV Crisis in Eastern Europe and Central Asia

July 22, 2024

From Gilead Sciences, Inc.

Via Business Wire

This Hidden Gem Vanguard ETF Is Chock-Full of Magnificent Stocks. Here's Why It's a Buy Now. ↗

July 21, 2024

This fund has a basket of growth, income, and value stocks.

Via The Motley Fool

Topics ETFs

Check Out What Whales Are Doing With GILD ↗

July 19, 2024

Via Benzinga

Gilead Sciences's Options Frenzy: What You Need to Know ↗

July 11, 2024

Via Benzinga

Looking Into Gilead Sciences's Recent Short Interest ↗

July 10, 2024

Via Benzinga

If You Can Only Buy One Biotech Stock in July, It Better Be One of These 3 Names ↗

July 19, 2024

Evaluating and making money from biotech stocks is incredibly difficult. These three ideas should help your quest if buying in July.

Via InvestorPlace

Chief Medical Officer Merdad Parsey to Leave Gilead Early 2025

July 17, 2024

From Gilead Sciences, Inc.

Via Business Wire

Want $3,000 In Passive Income? Invest $51,000 in These 3 High-Yield Dividend Plays ↗

July 17, 2024

These three dividend vehicles could provide reliable passive income.

Via The Motley Fool

Gilead to Highlight Landmark Progress in Research Across HIV Prevention, Treatment and Cure Programs at AIDS 2024

July 16, 2024

From Gilead Sciences, Inc.

Via Business Wire

If You Invested $1000 In This Stock 20 Years Ago, You Would Have $8,400 Today ↗

July 09, 2024

Via Benzinga

Key Takeaways From Gilead Sciences Analyst Ratings ↗

July 01, 2024

Via Benzinga

Gilead Sciences's Options Frenzy: What You Need to Know ↗

June 24, 2024

Via Benzinga

The 3 Most Undervalued Nasdaq 100 Stocks to Buy in July 2024 ↗

July 15, 2024

Undervalued Nasdaq 100 stocks may not be as rare as hen's teeth but not quite so plentiful amid a raging bull market.

Via InvestorPlace

Positive News is Driving This Cancer Drug Maker’s Stock Higher

July 15, 2024

IDEAYA Biosciences stock is up more than 16% on positive treatment data in a Phase 2 clinical trial, but after a 76% run-up, IDYA stock may need a breather

Via MarketBeat

3 Dividend Growth Stocks to Buy and Hold ↗

July 14, 2024

What's better than a dividend? A dividend that's growing.

Via The Motley Fool

Is Iovance Biotherapeutics a Millionaire Maker? ↗

July 14, 2024

This biotech's future is bright, but how good could it get for investors?

Via The Motley Fool

The 7 Most Undervalued Healthcare Stocks to Buy in July 2024 ↗

July 13, 2024

Explore undervalued healthcare stocks offering growth potential and stability in contrast to overvalued tech sector.

Via InvestorPlace

3 Underappreciated Stocks About to Break Their Chains ↗

July 11, 2024

Explore these underappreciated stocks ready for growth and get an in-depth analysis, forecasts, and news on these potential breakout stocks.

Via InvestorPlace

Oil Declines Amid Prospects Of An Agreement Between Israel And Hamas. Powell Will Address The Us Congress Today ↗

July 09, 2024

On Monday, the Dow Jones (US30) decreased by 0.08%, while the S&P 500 (US500) added 0.10%. The NASDAQ Technology Index (US100) closed positive 0.28%.

Via Talk Markets

Topics Stocks

7 Cheap Biotech Stocks With Major Upside Potential ↗

July 09, 2024

While the broader healthcare sector enjoys permanent relevance, you can potentially maximize your upside with cheap biotech stocks.

Via InvestorPlace

Healthcare Stocks Continue To Lag The Market-Can Anything Help ? ↗

July 08, 2024

Healthcare stocks continue to lag the market up about 6% YTD, helped by Large Cap Biopharma but hurt by United Health.

Via Talk Markets

This Domino's Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday ↗

July 08, 2024

Via Benzinga

Amgen, Inc. Dividend Stock Analysis ↗

July 05, 2024

Amgen Inc. is one of the world's leading biotech companies with major treatments for anemia, neutropenia, rheumatoid and psoriatic arthritis, psoriasis, cancer and osteoporosis.

Via Talk Markets

FDA Favorites: 3 Biotech Stocks on the Verge of Major Approvals ↗

July 04, 2024

Biotech stocks are on the verge of a comeback after a period of underperformance amid a wave of FDA approvals.

Via InvestorPlace

3 Undervalued Biotech Gems With 200%+ Analyst Price Targets ↗

July 04, 2024

These three undervalued biotech stocks have begun garnering investor attention as their treatments show promise.

Via InvestorPlace

3 Magnificent Stocks Retirees Can Buy and Hold Forever ↗

July 01, 2024

These stocks could be ideal for investors in their golden years.

Via The Motley Fool

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields ↗

June 28, 2024

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

June 25, 2024

Via Benzinga

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

71 72 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Gilead Sciences (NQ:GILD)

All News about Gilead Sciences

Starting at $3.75/week.

Subscribe Today